Sessions Were Renumbered as of May 19.
Legend:
CC-W = McCormick Place Convention Center, West Building,
CC-N = McCormick Place Convention Center, North Building
H = Hilton Chicago,
UC = Conference Chicago at University Center
* = applied session ! = JSM meeting theme
Activity Details
75 * !
Sun, 7/31/2016,
4:00 PM -
5:50 PM
CC-W194a
Bayesian Methods and Applications — Contributed Papers
Biopharmaceutical Section , International Society for Bayesian Analysis (ISBA) , Section on Bayesian Statistical Science
Chair(s): Paulette Ceesay, Merck
4:05 PM
Use of Bayesian Approach for the Design and Evaluation of Multiregional Clinical Trials
—
Chinfu Hsiao, National Health Research Institutes ; Yu-Chieh Cheng, National Chiao Tung University ; Hsiuying Wang, National Chiao Tung University
4:20 PM
Comparing Parametric and Semiparametric Bayesian Models for Subgroup Analysis in Clinical Trials
—
Margaret Gamalo-Siebers, Eli Lilly and Company
4:35 PM
Bayesian Clinical Trial Design for Survival Studies with Historical Study Data Under a Proportional Hazards Assumption
—
Matthew Psioda, The University of North Carolina at Chapel Hill ; Joseph G. Ibrahim, The University of North Carolina at Chapel Hill
4:50 PM
Shelf Life Estimation: Bayesian Approach
—
Maryna Ptukhina ; Walter Stroup, University of Nebraska - Lincoln
5:05 PM
The Case for Bayesian Methods in Benefit-Risk Assessment: Overview and Future Directions
—
Carl DiCasoli, Bayer HealthCare Pharmaceuticals ; Yannis Jemiai, Cytel ; Maria Costa, GlaxoSmithKline ; Weili He, Merck ; Yueqin Zhao, FDA/CDER
5:35 PM
Bayesian Methods in Phase 3 HCV Trials: Borrowing Historical Control Arm Data
—
Ran Liu, AbbVie ; Qi Tang, AbbVie ; Martin King, AbbVie ; Bo Fu, AbbVie ; Sandra Lovell, AbbVie ; Alan Hartford, AbbVie
